Global Peripheral Artery Disease Market Size and Forecast 2024-2033|Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc.

The Peripheral Artery Disease Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Peripheral Artery Disease Market:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

According to The Business Research Company’s Peripheral Artery Disease Global Market Report 2024, The peripheral artery disease market size has grown strongly in recent years. It will grow from $3.97 billion in 2023 to $4.28 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing prevalence of risk factors, growing aging population, clinical research and evidence-based medicine, awareness and screening programs, government healthcare initiatives..

The peripheral artery disease market size is expected to see strong growth in the next few years. It will grow to $5.67 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to focus on patient-centric care, advancements in minimally invasive procedures, digital health and remote monitoring, regenerative medicine approaches, targeted drug therapies.. Major trends in the forecast period include health equity initiatives, integration of wearable devices, expansion of home-based rehabilitation, patient-reported outcomes (pros), shift to outpatient settings.

The rise in the prevalence of peripheral artery diseases is expected to propel the growth of the peripheral artery disease market going forward. Peripheral artery disease refers to the narrowing or blockage of arteries outside the heart, usually in the legs, resulting in reduced blood flow and potential complications. Peripheral artery disease treatment helps reduce peripheral artery disease symptoms, enhance mobility, and decrease the risk of severe complications that improve patients’ well-being. For instance, in April 2023, according to HMP Communications LLC, a US-based patient-centered education resource, the global prevalence of peripheral artery disease increased from 11.3 million in 1995 to 21 million in 2020 and estimated to reach 23.8 million by 2030. Therefore, the rise in the prevalence of peripheral artery diseases is driving the growth of the peripheral artery disease market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route of Administration: Oral, Parenteral, Other Routes of Administration

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Technological advancements are a key trend gaining popularity in the peripheral artery disease market. Major companies operating in the peripheral artery disease market are adopting technologically advanced surgery treatments to sustain their position in the market. For instance, in November 2022, Genesis MedTech Group, a Singapore-based medical device company, introduced chocolate touch paclitaxel DCB catheter, a percutaneous transluminal angioplasty (PTA) catheter for the treatment of patients with superficial femoral artery and popliteal artery disease. The Chocolate Touch drug-coated balloon is the first and only balloon catheter in the device that combines therapeutic agent administration with a next-generation angioplasty platform for treating peripheral artery disease. It uses pillow-like structures covered with a therapeutic chemical to open in tiny parts to offer an alternate therapy to standard drug-coated balloon angioplasty for individuals suffering from peripheral artery disease. As a result, the balloon surface increases, allowing for more effective medication delivery to the vessel wall and eliminating the requirement for permanent implants.

The peripheral artery disease market report table of contents includes:

1. Executive Summary

2. Peripheral Artery Disease Market Characteristics

3. Peripheral Artery Disease Market Trends And Strategies

4. Peripheral Artery Disease Market – Macro Economic Scenario

5. Global Peripheral Artery Disease Market Size and Growth

26. South America Peripheral Artery Disease Market

27. Brazil Peripheral Artery Disease Market

28. Middle East Peripheral Artery Disease Market

29. Africa Peripheral Artery Disease Market

30. Peripheral Artery Disease Market Competitive Landscape And Company Profiles

Top Major Players: